Transfer from simulation to real world through learning deep inverse dynamics model
Developing control policies in simulation is often more practical and safer than directly
running experiments in the real world. This applies to policies obtained from planning and …
running experiments in the real world. This applies to policies obtained from planning and …
[HTML][HTML] Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration
PURPOSE Understanding the immunobiology of the 15% to 30% of patients with follicular
lymphoma (FL) who experience progression of disease within 24 months (POD24) remains a …
lymphoma (FL) who experience progression of disease within 24 months (POD24) remains a …
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
Primary central nervous system lymphoma (PCNSL) is confined to the brain, eyes, and
cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL occurs in the context of …
cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL occurs in the context of …
Occipital nerve blocks: when and what to inject?
Introduction.— Occipital nerve block (ONB) is a promising treatment for headaches. Its
indications, selection criteria, and best techniques are not clear, however. Objective.— To …
indications, selection criteria, and best techniques are not clear, however. Objective.— To …
[PDF][PDF] Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma
Tumor cells orchestrate their microenvironment. Here, we provide biochemical, structural,
functional, and clinical evidence that Cathepsin S (CTSS) alterations induce a tumor-…
functional, and clinical evidence that Cathepsin S (CTSS) alterations induce a tumor-…
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
…, G Thillaiyampalam, E Abro, JW Tobin… - Blood …, 2020 - ashpublications.org
Chimeric antigen receptor T-cell (CAR-T) therapy yields durable responses in patients with
relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). Cytokine release syndrome (…
relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL). Cytokine release syndrome (…
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
Objective Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma (EBV ‐pos DLBCL) is a
recently identified entity. Data regarding outcome to frontline immuno‐chemotherapy are …
recently identified entity. Data regarding outcome to frontline immuno‐chemotherapy are …
[HTML][HTML] Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
B-cell non-Hodgkin lymphoma (B-NHL) encompasses multiple clinically and phenotypically
distinct subtypes of malignancy with unique molecular etiologies. Common subtypes of B-…
distinct subtypes of malignancy with unique molecular etiologies. Common subtypes of B-…
Lasmiditan for the acute treatment of migraine: subgroup analyses by prior response to triptans
Background Lasmiditan demonstrated superiority to placebo in the acute treatment of migraine
in adults with moderate/severe migraine disability in two similarly designed Phase 3 trials…
in adults with moderate/severe migraine disability in two similarly designed Phase 3 trials…
Bystander CPR is associated with improved neurologically favourable survival in cardiac arrest following drowning
Background Cardiac arrest associated with drowning is a major public health concern with
limited research available on outcome. This investigation aims to define the population at risk, …
limited research available on outcome. This investigation aims to define the population at risk, …